vs
Side-by-side financial comparison of Organon & Co. (OGN) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.3× StoneX Group Inc.). StoneX Group Inc. runs the higher net margin — 11.6% vs -13.6%, a 25.2% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $-1.3B). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).
OGN vs SNEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.2B |
| Net Profit | $-205.0M | $139.0M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | 15.4% |
| Net Margin | -13.6% | 11.6% |
| Revenue YoY | -5.3% | 81.0% |
| Net Profit YoY | -288.1% | 63.3% |
| EPS (diluted) | $-0.78 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.6B | $32.7B | ||
| Q2 25 | $1.6B | $851.2M | ||
| Q1 25 | $1.5B | $820.4M | ||
| Q4 24 | $1.6B | $663.1M | ||
| Q3 24 | $1.6B | $31.1B | ||
| Q2 24 | $1.6B | $571.8M | ||
| Q1 24 | $1.6B | $509.2M |
| Q4 25 | $-205.0M | $139.0M | ||
| Q3 25 | $160.0M | $85.7M | ||
| Q2 25 | $145.0M | $63.4M | ||
| Q1 25 | $87.0M | $71.7M | ||
| Q4 24 | $109.0M | $85.1M | ||
| Q3 24 | $359.0M | $76.7M | ||
| Q2 24 | $195.0M | $61.9M | ||
| Q1 24 | $201.0M | $53.1M |
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | 3.7% | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | 3.0% | ||
| Q2 24 | 58.4% | — | ||
| Q1 24 | 59.0% | — |
| Q4 25 | -9.8% | 15.4% | ||
| Q3 25 | 15.2% | 0.3% | ||
| Q2 25 | 14.4% | -1.3% | ||
| Q1 25 | 6.7% | -1.0% | ||
| Q4 24 | 8.1% | -3.2% | ||
| Q3 24 | 13.1% | -0.0% | ||
| Q2 24 | 14.6% | -4.7% | ||
| Q1 24 | 14.5% | -2.5% |
| Q4 25 | -13.6% | 11.6% | ||
| Q3 25 | 10.0% | 0.3% | ||
| Q2 25 | 9.1% | 7.4% | ||
| Q1 25 | 5.8% | 8.7% | ||
| Q4 24 | 6.8% | 12.8% | ||
| Q3 24 | 22.7% | 0.2% | ||
| Q2 24 | 12.1% | 10.8% | ||
| Q1 24 | 12.4% | 10.4% |
| Q4 25 | $-0.78 | $2.50 | ||
| Q3 25 | $0.61 | $0.72 | ||
| Q2 25 | $0.56 | $1.22 | ||
| Q1 25 | $0.33 | $1.41 | ||
| Q4 24 | $0.42 | $1.69 | ||
| Q3 24 | $1.38 | $2.32 | ||
| Q2 24 | $0.75 | $1.25 | ||
| Q1 24 | $0.78 | $1.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $1.6B |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $2.5B |
| Total Assets | $12.9B | $47.8B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $1.6B | ||
| Q3 25 | $672.0M | $1.6B | ||
| Q2 25 | $599.0M | $1.3B | ||
| Q1 25 | $547.0M | $1.3B | ||
| Q4 24 | $675.0M | $1.4B | ||
| Q3 24 | $763.0M | $1.3B | ||
| Q2 24 | $704.0M | $1.2B | ||
| Q1 24 | $575.0M | $1.3B |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | $2.5B | ||
| Q3 25 | $906.0M | $2.4B | ||
| Q2 25 | $733.0M | $2.0B | ||
| Q1 25 | $542.0M | $1.9B | ||
| Q4 24 | $472.0M | $1.8B | ||
| Q3 24 | $493.0M | $1.7B | ||
| Q2 24 | $144.0M | $1.6B | ||
| Q1 24 | $48.0M | $1.5B |
| Q4 25 | $12.9B | $47.8B | ||
| Q3 25 | $13.6B | $45.3B | ||
| Q2 25 | $13.5B | $34.3B | ||
| Q1 25 | $13.2B | $31.3B | ||
| Q4 24 | $13.1B | $29.6B | ||
| Q3 24 | $12.8B | $27.5B | ||
| Q2 24 | $12.2B | $25.9B | ||
| Q1 24 | $11.9B | $25.7B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $-1.3B |
| Free Cash FlowOCF − Capex | $96.0M | $-1.3B |
| FCF MarginFCF / Revenue | 6.4% | -106.4% |
| Capex IntensityCapex / Revenue | 3.0% | 1.3% |
| Cash ConversionOCF / Net Profit | — | -9.08× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $3.5B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $-1.3B | ||
| Q3 25 | $264.0M | $3.5B | ||
| Q2 25 | $220.0M | $1.5B | ||
| Q1 25 | $75.0M | $-154.5M | ||
| Q4 24 | $390.0M | $-477.8M | ||
| Q3 24 | $141.0M | $192.6M | ||
| Q2 24 | $332.0M | $-622.1M | ||
| Q1 24 | $76.0M | $784.0M |
| Q4 25 | $96.0M | $-1.3B | ||
| Q3 25 | $218.0M | $3.5B | ||
| Q2 25 | $181.0M | $1.5B | ||
| Q1 25 | $43.0M | $-169.8M | ||
| Q4 24 | $335.0M | $-491.4M | ||
| Q3 24 | $99.0M | $175.9M | ||
| Q2 24 | $300.0M | $-640.5M | ||
| Q1 24 | $30.0M | $766.6M |
| Q4 25 | 6.4% | -106.4% | ||
| Q3 25 | 13.6% | 10.7% | ||
| Q2 25 | 11.4% | 173.3% | ||
| Q1 25 | 2.8% | -20.7% | ||
| Q4 24 | 21.0% | -74.1% | ||
| Q3 24 | 6.3% | 0.6% | ||
| Q2 24 | 18.7% | -112.0% | ||
| Q1 24 | 1.8% | 150.5% |
| Q4 25 | 3.0% | 1.3% | ||
| Q3 25 | 2.9% | 0.1% | ||
| Q2 25 | 2.4% | 1.9% | ||
| Q1 25 | 2.1% | 1.9% | ||
| Q4 24 | 3.5% | 2.1% | ||
| Q3 24 | 2.7% | 0.1% | ||
| Q2 24 | 2.0% | 3.2% | ||
| Q1 24 | 2.8% | 3.4% |
| Q4 25 | — | -9.08× | ||
| Q3 25 | 1.65× | 41.18× | ||
| Q2 25 | 1.52× | 23.52× | ||
| Q1 25 | 0.86× | -2.15× | ||
| Q4 24 | 3.58× | -5.61× | ||
| Q3 24 | 0.39× | 2.51× | ||
| Q2 24 | 1.70× | -10.05× | ||
| Q1 24 | 0.38× | 14.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
